Cardiac Surgery, Extracorporeal Circulation, Fibrinogen
Conditions
Brief summary
Multicenter prospective observational study, involving all adult patients who underwent cardiac surgery with extracorporeal circulation
Interventions
None listed
Sponsors
Keyrus Biopharma
Société Française d'Anesthésie et de Réanimation
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patient over the age of 18 that underwent a cardiac surgery with extracorporeal circulation. * Patient who agreed to participate in the study.
Exclusion criteria
* Patient under the age of 18.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The international recommendations published by ESA in 2016 | 13 Months | Review the concordance between the presence / absence of indication (according to the international recommendations published by ESA in 2016) and the prescription / non-prescription of fibrinogen concentrates |
Contacts
Primary ContactLongrois Dan, Pr
Outcome results
None listed